Skip to content

The Science, Clinical Trials, Physicians, And Patients’ Everyday Lives Behind NPS Pharmaceuticals’ Orphan Drug Gattex (Teduglutide) For Short Bowel Syndrome

December 21, 2012

       After the FDA Approval on December 21, 2012, of NPS Pharmaceuticals’ orphan drug Gattex (Teduglutide) for adult Short Bowel Syndrome (SBS), the company posts an excellent video to YouTube.com for viewing.

       It is worth the time to view the YouTube.com Video. The video covers the following topics :

  1. Background on Gattex
  2. Description of SBS indication
  3. Gattex Safety Information
  4. Animation of the SBS disease
  5. Gattex clinical trials
  6. Experiences with SBS patients using Gattex – Dr. Ken Fujioka, Nutrition & Metabolic Research Center, Scripps Center, California
  7. Experiences with SBS patients using Gattex – Dr. Lauren Schwartz, Assistant Professor of GI Medicine, Mt. Sinai School of Medicine, New York City – Specialty is Intestinal Transplantation & Rehabilitation
  8. Several SBS patients discuss the impact Gattex has on their everyday lives and the tremendous improvement in their quality of life
  9. Contact information and Conclusion.

References

Orphan Druganaut Blog Post “What is the good news for NPS Pharmaceuticals’ orphan drug Gattex (Teduglutide) for SBS ?”

Orphan Druganaut Blog Post “Internet Chatter about December 21, 2012 FDA Approval of NPS Pharmaceuticals’ orphan drug Gattex (Teduglutide)”

Copyright © 2012-2013, Orphan Druganaut Blog. All rights reserved.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: